Previous 10 | Next 10 |
MINNEAPOLIS, March 15, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced it has received independent Institutional Review Board (IRB) approval for the trial protocol of the company’s REVERSE-HF (Ult r afiltration V e rsus I V Diur ...
Nuwellis, Inc. (NUWE) Q4 2021 Earnings Conference Call March 01, 2022 9:00 AM ET Company Participants Matt Bacso – Investor Relations Nestor Jaramillo – President and Chief Executive Officer George Montague – Chief Financial Officer Conference Call Participants Jeffrey Co...
Nuwellis press release (NASDAQ:NUWE): Q4 GAAP EPS of -$0.41 beats by $0.07. Revenue of $1.64M (-19.6% Y/Y) misses by $0.48M. For further details see: Nuwellis GAAP EPS of -$0.41 beats by $0.07, revenue of $1.64M misses by $0.48M
MINNEAPOLIS, March 01, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the fourth quarter and full year ended December 31, 2021, which included the following highlights: Generated $1.6 million in total revenue for the fourth quarter 2021, 19.6%...
Nuwellis (NASDAQ:NUWE) is scheduled to announce Q4 earnings results on Tuesday, March 1st, before market open. The consensus EPS Estimate is -$0.48 and the consensus Revenue Estimate is $2.12M (+6.0% Y/Y). For further details see: Nuwellis Q4 2021 Earnings Preview
MINNEAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will evaluate the clinical outcomes and economic value of its Aquadex ® therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients wi...
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its fourth quarter 2022 financial results will be released on Tuesday, March 1, 2022. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the...
EDEN PRAIRIE, Minn., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that the new and dedicated Category III Current Procedural Terminology (CPT®) code, 0692T for Therapeutic Ultrafiltration, is now in effect. Healthcare providers can utilize thi...
MINNEAPOLIS, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective November 17, 2021, the independent directors approved an equity award under Nuwellis’ 2021 Inducement Plan, as a material inducement to an individual entering into employment...
Nuwellis, Inc. (NUWE) Q3 2021 Earnings Conference Call November 09, 2021, 09:00 AM ET Company Participants Matt Beckel - Gilmartin Group Nestor Jaramillo - President & CEO George Montague - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Brooks O'Neil - Lake Street Cap...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
MINNEAPOLIS, July 24, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities pu...
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter of 2024 on Tuesday, August 13, 2024. Nuwellis w...